W
Weiyi Ni
Researcher at University of Southern California
Publications - 25
Citations - 352
Weiyi Ni is an academic researcher from University of Southern California. The author has contributed to research in topics: Population & Health care. The author has an hindex of 8, co-authored 24 publications receiving 253 citations. Previous affiliations of Weiyi Ni include Medtronic plc & University of Florida.
Papers
More filters
Journal ArticleDOI
Super enhancer inhibitors suppress MYC driven transcriptional amplification and tumor progression in osteosarcoma.
Demeng Chen,Zhiqiang Zhao,Zixin Huang,Du-Chu Chen,Xinxing Zhu,Yi-Ze Wang,Ya-Wei Yan,Shaojun Tang,Subha Madhavan,Weiyi Ni,Zhan-Peng Huang,Wen Li,Weidong Ji,Huangxuan Shen,Shuibin Lin,Yi-Zhou Jiang +15 more
TL;DR: It is uncovered that the oncogene MYC is significantly upregulated in metastastic osteosarcoma samples, and high MYC expression is associated with poor survival and poor prognosis, and targeting the MYC/super enhancer axis represents as a promising therapeutic strategy for treatment of osteosARcoma patients.
Journal ArticleDOI
Estimating the Impact of Adherence to and Persistence with Atypical Antipsychotic Therapy on Health Care Costs and Risk of Hospitalization
Yawen Jiang,Weiyi Ni +1 more
TL;DR: To estimate the impact of adherence to and persistence with atypical antipsychotics on health care costs and risk of hospitalization by controlling potential sources of endogeneity.
Journal ArticleDOI
Longevity of rAAV vector and plasmid DNA in blood after intramuscular injection in nonhuman primates: implications for gene doping
Weiyi Ni,C. Le Guiner,Gwladys Gernoux,M Penaud-Budloo,M Penaud-Budloo,Philippe Moullier,Philippe Moullier,Richard O. Snyder,Richard O. Snyder +8 more
TL;DR: It is demonstrated that IM injection of a conventional plasmid and rAAV vectors results in the presence of DNA that can be detected at high levels in blood before rapid elimination, and that rAAVs genomes can persist for several months in WBCs.
Journal Article
Impact of a pharmacy-based transitional care program on hospital readmissions.
Weiyi Ni,Danielle Colayco,Jonathan Hashimoto,Kevin Komoto,Chandrakala Gowda,Bruce Wearda,Jeffrey S. McCombs +6 more
TL;DR: A community pharmacy-based postdischarge TOC program can significantly reduce readmission rates at 30 and 180 days compared with usual discharge care.
Journal ArticleDOI
Development and utility of an internal threshold control (ITC) real-time PCR assay for exogenous DNA detection.
Weiyi Ni,Caroline Le Guiner,Philippe Moullier,Philippe Moullier,Richard O. Snyder,Richard O. Snyder +5 more
TL;DR: A Taqman PCR-based approach that incorporates an internal threshold control (ITC) has been developed and was demonstrated in a nonhuman primate model of rAAV vector mediated gene doping in vivo and in human genomic DNA spiked with plasmid DNA.